LifeMD (LFMD) Stock Analysis & Winston Score
LifeMD is a telehealth company that connects patients with licensed doctors and then ships prescription medications and health products directly to their homes. Its main services cover weight loss, hair loss, erectile dysfunction, skincare, and mental health — all handled through online visits instead of in-person doctor appointments. The company operates brands like RexMD and Shapiro MD and sells primarily to adult consumers in the United States. LifeMD makes most of its money through recurring subscription plans where patients pay monthly or quarterly fees for ongoing care and medication refills. It operates almost entirely in the US and generates strong gross margins — around 86% — because it sells branded and compounded medications with relatively low product costs. However, the company is not yet profitable at the operating level, and its biggest risk is regulatory pressure on compounded GLP-1 weight-loss drugs, which have become a major growth driver but face increasing scrutiny from the FDA as branded alternatives become more widely available.
Winston Score: 26/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (10/30)
- Growth: Mixed (5/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $3.31
Market Cap: $160M
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Exchange: NASDAQ
